22Mar
HHS Declares Liability Immunity for Certain COVID-19 “Countermeasures”; Response Act Expands Protections for Mask Makers
Earlier this week, we discussed current trends and future implications of COVID-19 on businesses operating in the products arena, noting the most direct impact so far on the pharmaceutical and medical device spaces. Recognizing the potential...
By:
Butler Snow LLP
Related
Although there is no standard set of measures that a company can implement to guarantee that it will...
Read More >
On the heels of the broadest Pay Equity law in the country, New Jersey has just passed the broadest ...
Read More >
The SEC announced settled charges against Andeavor LLC for controls violations relating to a stock b...
Read More >
On January 6, 2020, Connecticut Governor Ned Lamont signed into law House Bill No. 7501 (An Act Conc...
Read More >
COVID-19 and the resulting economic uncertainty are adversely impacting businesses worldwide. Colora...
Read More >
This newsletter is our take on the antitrust developments we think are most interesting to your busi...
Read More >